Penny Stocks on the Move: Today’s Top Gainers and Biggest Decliners
Generado por agente de IAAinvest IPO News
martes, 10 de junio de 2025, 8:02 pm ET3 min de lectura
CARM--
On June 10, 2025, the penny stock market witnessed remarkable movements, with Carisma TherapeuticsCARM-- Inc. emerging as the top gainer, boasting an impressive increase of 388.99%. In contrast, Baiya International GroupBIYA-- Inc. experienced the most significant decline, with a dramatic drop of 50.38%. These fluctuations highlight the dynamic nature of the penny stock market, driven by strategic announcements and investor sentiment.
Top Gainers
Carisma Therapeutics Inc. (CARM)
Carisma Therapeutics Inc., a pharmaceutical company, saw its stock surge by 388.99% today, ranking first among penny stocks. The intraday high was $1.27, closing at $1.11. Recent reports indicate that Carisma's announcement on June 9 of a strategic pivot to prioritize fibrosis, oncology, and autoimmune disease therapies, alongside workforce reductions and collaboration with Moderna, have driven investor interest and contributed to the stock's remarkable rise.
Evogene Ltd. (EVGN)
Evogene Ltd., a biotechnology company, saw its stock soar by 100% today, ranking third among penny stocks. The stock reached an intraday high of $2.42 and closed at $2.26. Reports indicate that on June 7, 2025, Evogene completed its generative AI foundation model for small molecule design, driving a surge in investor interest. Additionally, Evogene's collaboration with Google Cloud unveiled a new model for discovering compounds on June 5, 2025, enhancing the company's strategic position in the industry.
Marin Software Incorporated (MRIN)
Marin Software Incorporated, operating in the media industry, experienced a notable stock surge, closing at $1.7, a 100% increase, ranking third among penny stocks today, with an intraday high of $1.76. Reports indicate Marin Software shares soared on June 9, 2025, due to potential private equity interest following its dissolution plans, prompting a significant market response amid Nasdaq scrutiny.
Nucana Plc (NCNA)
Nucana Plc saw a remarkable surge of 89.47% today, ranking fourth in the penny stock market, with an intraday high of 0.19 and closing at 0.14. The pharmaceutical company's stock rally is driven by recent reports indicating a promising financial report for the first quarter of 2025 and strategic updates announced on June 8, 2025. These developments have significantly improved investor sentiment and contributed to the stock's upward momentum.
Gelteq Limited (GELS)
Gelteq Limited, a company in the pharmaceutical industry, saw its stock soar by 73.53% today, ranking fifth among penny stocks. The stock hit an intraday high of 3.51 before closing at 2.95. Reports indicate that recent developments in Gelteq's U.S. expansion and distribution agreements have fueled the stock's momentum over the past five days, leading to heightened investor interest and stock price growth.
Top Decliners
Baiya International Group Inc. (BIYA)
Baiya International Group Inc., a company specializing in professional services, experienced a dramatic stock price drop today, plummeting by 50.38%, making it the leading decliner in the penny stock market. The stock saw an intraday low of $1.86 before closing at $1.97. Reports indicate that recent announcements of a partial waiver of lock-up restrictions, effective June 5, 2025, on shares held by major shareholders have contributed significantly to today's stock decline. News from June 5, 2025, suggests that the waiver allows early sales of shares post-IPO, sparking investor concern.
Unicycive Therapeutics, Inc. (UNCY)
Unicycive Therapeutics, Inc., a biotechnology company focusing on innovative treatments for kidney diseases, experienced a significant stock decline today, dropping by 40.89%. This ranks it as the second-largest fall in the penny stock market today. The stock hit an intraday low of 0.47 and closed at 0.53. Recent reports indicate that the U.S. Food and Drug Administration (FDA) flagged manufacturing issues related to Unicycive's new drug application, causing a sharp decline in its stock value. On June 10, 2025, analysts say the FDA identified deficiencies, contributing to the slide in the company's shares.
Wang & Lee Group, Inc. (WLGS)
Today, Wang & Lee Group, Inc. (WLGS), a construction products company, experienced a significant decline in its stock price, falling by 31.36%, ranking as the third-largest drop among today's penny stocks. The stock reached an intraday low of $0.08 and closed at $0.08. Reports indicate that on June 9, 2025, Wang & Lee Group announced a $12 million securities purchase agreement; however, analysts say the deal contributed to the stock's plunge due to concerns over dilution and bid price deficiency.
Marwynn Holdings, Inc. (MWYN)
Marwynn Holdings, Inc., operating in the distribution and retail of consumer goods industry, saw a significant stock drop today, with a change of -27.30%, ranking fourth among penny stocks. The stock's intraday low was 1.42, closing at 1.43. Recent reports indicate that trading was suspended after a volatility trading pause on June 8, 2025, contributing to today's plunge, alongside a previous announcement of decreased quarterly revenue by 12.36% for the period ending January 31, 2025.
Ohmyhome Limited (OMH)
Ohmyhome Limited, a player in the real estate management and development industry, experienced a sharp decline today with its stock plummeting by 26.14%, securing the fifth spot in today's penny stock market drop. The stock hit an intraday low of $1.35 and closed at $1.78. Reports indicate that Ohmyhome's recent plunge follows the announcement on June 8, 2025, of a reverse stock split effective March 10, 2025, and an SEC filing revealing a stock sale agreement with qualified investors, raising concerns among analysts about future dilution risks.
Top Gainers
Carisma Therapeutics Inc. (CARM)
Carisma Therapeutics Inc., a pharmaceutical company, saw its stock surge by 388.99% today, ranking first among penny stocks. The intraday high was $1.27, closing at $1.11. Recent reports indicate that Carisma's announcement on June 9 of a strategic pivot to prioritize fibrosis, oncology, and autoimmune disease therapies, alongside workforce reductions and collaboration with Moderna, have driven investor interest and contributed to the stock's remarkable rise.
Evogene Ltd. (EVGN)
Evogene Ltd., a biotechnology company, saw its stock soar by 100% today, ranking third among penny stocks. The stock reached an intraday high of $2.42 and closed at $2.26. Reports indicate that on June 7, 2025, Evogene completed its generative AI foundation model for small molecule design, driving a surge in investor interest. Additionally, Evogene's collaboration with Google Cloud unveiled a new model for discovering compounds on June 5, 2025, enhancing the company's strategic position in the industry.
Marin Software Incorporated (MRIN)
Marin Software Incorporated, operating in the media industry, experienced a notable stock surge, closing at $1.7, a 100% increase, ranking third among penny stocks today, with an intraday high of $1.76. Reports indicate Marin Software shares soared on June 9, 2025, due to potential private equity interest following its dissolution plans, prompting a significant market response amid Nasdaq scrutiny.
Nucana Plc (NCNA)
Nucana Plc saw a remarkable surge of 89.47% today, ranking fourth in the penny stock market, with an intraday high of 0.19 and closing at 0.14. The pharmaceutical company's stock rally is driven by recent reports indicating a promising financial report for the first quarter of 2025 and strategic updates announced on June 8, 2025. These developments have significantly improved investor sentiment and contributed to the stock's upward momentum.
Gelteq Limited (GELS)
Gelteq Limited, a company in the pharmaceutical industry, saw its stock soar by 73.53% today, ranking fifth among penny stocks. The stock hit an intraday high of 3.51 before closing at 2.95. Reports indicate that recent developments in Gelteq's U.S. expansion and distribution agreements have fueled the stock's momentum over the past five days, leading to heightened investor interest and stock price growth.
Top Decliners
Baiya International Group Inc. (BIYA)
Baiya International Group Inc., a company specializing in professional services, experienced a dramatic stock price drop today, plummeting by 50.38%, making it the leading decliner in the penny stock market. The stock saw an intraday low of $1.86 before closing at $1.97. Reports indicate that recent announcements of a partial waiver of lock-up restrictions, effective June 5, 2025, on shares held by major shareholders have contributed significantly to today's stock decline. News from June 5, 2025, suggests that the waiver allows early sales of shares post-IPO, sparking investor concern.
Unicycive Therapeutics, Inc. (UNCY)
Unicycive Therapeutics, Inc., a biotechnology company focusing on innovative treatments for kidney diseases, experienced a significant stock decline today, dropping by 40.89%. This ranks it as the second-largest fall in the penny stock market today. The stock hit an intraday low of 0.47 and closed at 0.53. Recent reports indicate that the U.S. Food and Drug Administration (FDA) flagged manufacturing issues related to Unicycive's new drug application, causing a sharp decline in its stock value. On June 10, 2025, analysts say the FDA identified deficiencies, contributing to the slide in the company's shares.
Wang & Lee Group, Inc. (WLGS)
Today, Wang & Lee Group, Inc. (WLGS), a construction products company, experienced a significant decline in its stock price, falling by 31.36%, ranking as the third-largest drop among today's penny stocks. The stock reached an intraday low of $0.08 and closed at $0.08. Reports indicate that on June 9, 2025, Wang & Lee Group announced a $12 million securities purchase agreement; however, analysts say the deal contributed to the stock's plunge due to concerns over dilution and bid price deficiency.
Marwynn Holdings, Inc. (MWYN)
Marwynn Holdings, Inc., operating in the distribution and retail of consumer goods industry, saw a significant stock drop today, with a change of -27.30%, ranking fourth among penny stocks. The stock's intraday low was 1.42, closing at 1.43. Recent reports indicate that trading was suspended after a volatility trading pause on June 8, 2025, contributing to today's plunge, alongside a previous announcement of decreased quarterly revenue by 12.36% for the period ending January 31, 2025.
Ohmyhome Limited (OMH)
Ohmyhome Limited, a player in the real estate management and development industry, experienced a sharp decline today with its stock plummeting by 26.14%, securing the fifth spot in today's penny stock market drop. The stock hit an intraday low of $1.35 and closed at $1.78. Reports indicate that Ohmyhome's recent plunge follows the announcement on June 8, 2025, of a reverse stock split effective March 10, 2025, and an SEC filing revealing a stock sale agreement with qualified investors, raising concerns among analysts about future dilution risks.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios